Tag Archives: denvax

Immunotherapy for Oncological Cancer: ASCO Focus

Dr. Jamal’s DENVAX is a Dendritic Cell (DC)-based cancer immunotherapy that prevents to the recurrence of cancer after surgery, chemotherapy or radiation because the immune system will need to recognize and attack a smaller number of cancer cells, which was the main theme of the ASCO event…

Read more »
Posted in Oncology, Press Releases, Press Releases Featured 2 | Also tagged , | Volume: | Leave a comment
  • Follow mdCurrent Health for the latest health news!

    Email Newsletter